Skip to main content

Table 3 Number and stage of patients in the Post-EBUS cohort (N = 326) who had EBUS

From: Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study

 

EBUS-GS group

EBUS-TBNA group

Stage (n)

n (%a)

n (%a)

NSCLC

  

 I (55)

9 (16.4)

6 (10.9)

 II (23)

4 (17.4)

2 (8.7)

 III (75)

9 (12.0)

23 (30.7)

 IV (135)

12 (8.9)

21 (15.6)

SCLC

  

 Limited (18)

0 (0)

8 (44.4)

 Extensive (20)

0 (0)

2 (10.0)

 Overall (326)

34 (10.4)b

62 (19.0)b

  1. aPercentage within cancer stage
  2. bIncludes 6 patients who had both EBUS-GS and EBUS-TBNA
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us